Could a parasite drug boost cancer immunotherapy? new trial investigates
Disease control
Recruiting now
This study tests whether adding ivermectin (a common anti-parasite drug) to standard immunotherapy can help shrink tumors in people with metastatic triple-negative breast cancer. About 34 adults whose cancer has spread will receive the combination. The goal is to find the best do…
Phase: PHASE1, PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated May 15, 2026 11:53 UTC